Functional validation of tensin2 SH2-PTB domain by CRISPR/Cas9-mediated genome editing

Journal of Veterinary Medical Science

Volumn 78, Issue 9, 2016, Pages 1413-1420

  Marusugi, Kiyoma ^a   Nakano, Kenta ^a,b   Sasaki, Hayato ^a   Kimura, Junpei ^c   Yanobu Takanashi, Rieko ^b   Okamura, Tadashi ^b   Sasaki, Nobuya ^a  

^a KITASATO UNIVERSITY   (Japan)

^b NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^c HOKKAIDO UNIVERSITY   (Japan)

Author keywords

CRISPR Cas9; Glomerular sclerosis; Podocyte; SH2 PTB domain; Tensin2

Indexed keywords

POLYPYRIMIDINE TRACT BINDING PROTEIN; TENSIN; TNS2 PROTEIN, MOUSE;

ANIMAL; CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEAT; DISEASE MODEL; FEMALE; GENETICS; GLOMERULUS; KNOCKOUT MOUSE; METABOLISM; MOUSE; MUTATION; PATHOLOGY; PHYSIOLOGY; PODOCYTE; PROTEINURIA; SCLEROSIS;

ANIMALS; CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEATS; DISEASE MODELS, ANIMAL; FEMALE; KIDNEY GLOMERULUS; MICE; MICE, KNOCKOUT; MUTATION; PODOCYTES; POLYPYRIMIDINE TRACT-BINDING PROTEIN; PROTEINURIA; SCLEROSIS; TENSINS;

EID: 84989332755     PISSN: 09167250     EISSN: 13477439     Source Type: Journal    
DOI: 10.1292/jvms.16-0205     Document Type: Article

References (38)

1. Akilesh, S., Suleiman, H., Yu, H., Stander, M. C., Lavin, P., Gbadegesin, R., Antignac, C., Pollak, M., Kopp, J. B., Winn, M. P. and Shaw, A. S. 2011. Arhgap24 inactivates Rac1 in mouse podocytes, and a mutant form is associated with familial focal segmental glomerulosclerosis. J. Clin. Invest. 121: 4127–4137.
2. Basak, P., Dillon, R., Leslie, H., Raouf, A. and Mowat, M. R. 2015. The Deleted in Liver Cancer 1 (Dlc1) tumor suppressor is haploinsufficient for mammary gland development and epithelial cell polarity. BMC Cancer 15: 630.
3. Calderwood, D. A., Fujioka, Y., de Pereda, J. M., García-Alvarez, B., Nakamoto, T., Margolis, B., McGlade, C. J., Liddington, R. C. and Ginsberg, M. H. 2003. Integrin beta cytoplasmic domain interactions with phosphotyrosine-binding domains: a structural prototype for diversity in integrin signaling. Proc. Natl. Acad. Sci. U.S.A. 100: 2272–2277.
4. Chan, L. K., Ko, F. C., Ng, I. O. and Yam, J. W. 2009. Deleted in liver cancer 1 (DLC1) utilizes a novel binding site for Tensin2 PTB domain interaction and is required for tumor-suppressive function. PLOS ONE 4: e5572.
5. Chen, H. and Lo, S. H. 2003. Regulation of tensin-promoted cell migration by its focal adhesion binding and Src homology domain 2. Biochem. J. 370: 1039–1045.
6. Cho, A. R., Uchio-Yamada, K., Torigai, T., Miyamoto, T., Miyoshi, I., Matsuda, J., Kurosawa, T., Kon, Y., Asano, A., Sasaki, N. and Agui, T. 2006. Deficiency of the tensin2 gene in the ICGN mouse: an animal model for congenital nephrotic syndrome. Mamm. Genome 17: 407–416.
7. Deller, T., Korte, M., Chabanis, S., Drakew, A., Schwegler, H., Stefani, G. G., Zuniga, A., Schwarz, K., Bonhoeffer, T., Zeller, R., Frotscher, M. and Mundel, P. 2003. Synaptopodin-deficient mice lack a spine apparatus and show deficits in synaptic plasticity. Proc. Natl. Acad. Sci. U.S.A. 100: 10494–10499.
8. Durkin, M. E., Avner, M. R., Huh, C. G., Yuan, B. Z., Thorgeirsson, S. S. and Popescu, N. C. 2005. DLC-1, a Rho GTPase-ac-tivating protein with tumor suppressor function, is essential for embryonic development. FEBS Lett. 579: 1191–1196.
9. Gee, H. Y., Saisawat, P., Ashraf, S., Hurd, T. W., Vega-Warner, V., Fang, H., Beck, B. B., Gribouval, O., Zhou, W., Diaz, K. A., Natarajan, S., Wiggins, R. C., Lovric, S., Chernin, G., Schoeb, D. S., Ovunc, B., Frishberg, Y., Soliman, N. A., Fathy, H. M., Goebel, H., Hoefele, J., Weber, L. T., Innis, J. W., Faul, C., Han, Z., Washburn, J., Antignac, C., Levy, S., Otto, E. A. and Hildebrandt, F. 2013. ARHGDIA mutations cause nephrotic syndrome via defective RHO GTPase signaling. J. Clin. Invest. 123: 3243–3253.
10. Grenz, H., Carbonetto, S. and Goodman, S. L. 1993. Alpha 3 beta 1 integrin is moved into focal contacts in kidney mesangial cells. J. Cell Sci. 105: 739–751.
11. Haynie, D. T. 2014. Molecular physiology of the tensin brotherhood of integrin adaptor proteins. Proteins 82: 1113–1127.
12. He, F. F., Chen, S., Su, H., Meng, X. F. and Zhang, C. 2013. Actin-associated proteins in the pathogenesis of podocyte injury. Curr. Genomics 14: 477–484.
13. Jin, X., Wang, W., Mao, J., Shen, H., Fu, H., Wang, X., Gu, W., Liu, A., Yu, H., Shu, Q. and Du, L. 2014. Overexpression of Myo1e in mouse podocytes enhances cellular endocytosis, migration, and adhesion. J. Cell. Biochem. 115: 410–419.
14. Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A. and Charpentier, E. 2012. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science 337: 816–821.
15. Kaplan, J. M., Kim, S. H., North, K. N., Rennke, H., Correia, L. A., Tong, H. Q., Mathis, B. J., Rodríguez-Pérez, J. C., Allen, P. G., Beggs, A. H. and Pollak, M. R. 2000. Mutations in ACTN4, encoding alpha-actinin-4, cause familial focal segmental glomerulosclerosis. Nat. Genet. 24: 251–256.
16. Kelley, M. J., Jawien, W., Ortel, T. L. and Korczak, J. F. 2000. Mutation of MYH9, encoding non-muscle myosin heavy chain A, in May-Hegglin anomaly. Nat. Genet. 26: 106–108.
17. Kim, J. M., Wu, H., Green, G., Winkler, C. A., Kopp, J. B., Miner, J. H., Unanue, E. R. and Shaw, A. S. 2003. CD2-associated protein haploinsufficiency is linked to glomerular disease susceptibility. Science 300: 1298–1300.
18. Knepper, M. A. Podocyte Transcriptome. Available at https:// hpcwebapps.cit.nih.gov/ESBL/Database/Podocyte_Transcrip-tome/index.htm (Accessed 2 May 2016).
19. Lo, S. H. 2004. Tensin. Int. J. Biochem. Cell Biol. 36: 31–34.
20. Mali, P., Esvelt, K. M. and Church, G. M. 2013. Cas9 as a versatile tool for engineering biology. Nat. Methods 10: 957–963.
21. Martuszewska, D., Ljungberg, B., Johansson, M., Landberg, G., Oslakovic, C., Dahlbäck, B. and Hafizi, S. 2009. Tensin3 is a negative regulator of cell migration and all four Tensin family members are downregulated in human kidney cancer. PLOS ONE 4: e4350.
22. Mathieson, P. W. 2012. The podocyte cytoskeleton in health and in disease. Clin. Kidney J. 5: 498–501.
23. Mundel, P., Schwarz, K. and Reiser, J. 2001. Podocyte biology: a footstep further. Adv. Nephrol. Necker Hosp. 31: 235–241.
24. Mundel, P. and Reiser, J. 2010. Proteinuria: an enzymatic disease of the podocyte? Kidney Int. 77: 571–580.
25. Mundel, P., Reiser, J., Zúñiga Mejía Borja, A., Pavenstädt, H., Davidson, G. R., Kriz, W. and Zeller, R. 1997. Rearrangements of the cytoskeleton and cell contacts induce process formation during differentiation of conditionally immortalized mouse podocyte cell lines. Exp. Cell Res. 236: 248–258.
26. Nishino, T., Sasaki, N., Chihara, M., Nagasaki, K., Torigoe, D., Kon, Y. and Agui, T. 2012. Distinct distribution of the tensin family in the mouse kidney and small intestine. Exp. Anim. 61: 525–532.
27. Nitta, T., Muro, R., Shimizu, Y., Nitta, S., Oda, H., Ohte, Y., Goto, M., Yanobu-Takanashi, R., Narita, T., Takayanagi, H., Yasuda, H., Okamura, T., Murata, S. and Suzuki, H. 2015. The thymic cortical epithelium determines the TCR repertoire of IL-17-producing γδT cells. EMBO Rep. 16: 638–653.
28. Ogura, A., Asano, T., Matsuda, J. and Fujimura, H. 1991. Evolution of glomerular lesions in nephrotic ICGN mice: serial biopsy study with electron microscopy. J. Vet. Med. Sci. 53: 513–515.
29. Ogura, A., Asano, T., Matsuda, J., Takano, K., Nakagawa, M. and Fukui, M. 1989. Characteristics of mutant mice (ICGN) with spontaneous renal lesions: a new model for human nephrotic syndrome. Lab. Anim. 23: 169–174.
30. Pavenstädt, H., Kriz, W. and Kretzler, M. 2003. Cell biology of the glomerular podocyte. Physiol. Rev. 83: 253–307.
31. Pozzi, A., Jarad, G., Moeckel, G. W., Coffa, S., Zhang, X., Gewin, L., Eremina, V., Hudson, B. G., Borza, D. B., Harris, R. C., Holzman, L. B., Phillips, C. L., Fassler, R., Quaggin, S. E., Miner, J. H. and Zent, R. 2008. Beta1 integrin expression by podocytes is required to maintain glomerular structural integrity. Dev. Biol. 316: 288–301.
32. Sasaki, H., Sasaki, N., Nishino, T., Nagasaki, K., Kitamura, H., Torigoe, D. and Agui, T. 2014. Quantitative trait loci for resistance to the congenital nephropathy in tensin 2-deficient mice. PLOS ONE 9: e99602.
33. Sasaki, H., Marusugi, K., Kimura, J., Kitamura, H., Nagasaki, K., Torigoe, D., Agui, T. and Sasaki, N. 2015. Genetic background-dependent diversity in renal failure caused by the tensin2 gene deficiency in the mouse. Biomed. Res. 36: 323–330.
34. Shih, Y. P., Sun, P., Wang, A. and Lo, S. H. 2015. Tensin1 positively regulates RhoA activity through its interaction with DLC1. Biochim. Biophys. Acta 1853: 3258–3265.
35. Uchio-Yamada, K., Sawada, K., Tamura, K., Katayama, S., Monobe, Y., Yamamoto, Y., Ogura, A. and Manabe, N. 2013. Tenc1-deficient mice develop glomerular disease in a strain-specific manner. Nephron, Exp. Nephrol. 123: 22–33.
36. Wiggins, R. C. 2007. The spectrum of podocytopathies: a unifying view of glomerular diseases. Kidney Int. 71: 1205–1214.
37. Xue, W., Krasnitz, A., Lucito, R., Sordella, R., Vanaelst, L., Cordon-Cardo, C., Singer, S., Kuehnel, F., Wigler, M., Powers, S., Zender, L. and Lowe, S. W. 2008. DLC1 is a chromosome 8p tumor suppressor whose loss promotes hepatocellular carcinoma. Genes Dev. 22: 1439–1444.
38. Yam, J. W., Ko, F. C., Chan, C. Y., Jin, D. Y. and Ng, I. O. 2006. Interaction of deleted in liver cancer 1 with tensin2 in caveolae and implications in tumor suppression. Cancer Res. 66: 8367– 8372.